Last Posted: Aug 05, 2019
- Emily and Caroline’s Story
CDC Bring Your Brave, 2019 - Evaluation of tumor-infiltrating lymphocytes and association with prognosis in BRCA-mutated breast cancer.
Sønderstrup I M H et al. Acta oncologica (Stockholm, Sweden) 2019 Mar 58(3) 363-370 - Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case-control study.
Zayas-Villanueva Omar Alejandro et al. BMC cancer 2019 Jul 19(1) 722 - Somatic variants of potential clinical significance in the tumors of BRCA phenocopies.
Buckingham Lela et al. Hereditary cancer in clinical practice 2019 1721 - Association of Germline BRCA2 Mutations With the Risk of Pediatric or Adolescent Non-Hodgkin Lymphoma.
Wang Zhaoming et al. JAMA oncology 2019 Jul - PARP inhibition - opportunities in pancreatic cancer.
Pant Shubham et al. Nature reviews. Clinical oncology 2019 Jul - Breast reconstruction after risk-reducing mastectomy in BRCA mutation carriers.
Nagura Naomi et al. Breast cancer (Tokyo, Japan) 2019 Jul - Brief Report: Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.
Zauderer Marjorie G et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2019 Jul - Choosing high-risk screening vs. surgery and the effect of treatment modality on anxiety and breast-specific sensuality in BRCA mutation carriers.
Rojas Kristin E et al. Gland surgery 2019 Jun 8(3) 249-257 - Evaluating BRCA mutation risk predictive models in a Chinese cohort in Taiwan.
Hung Fei-Hung et al. Scientific reports 2019 Jul 9(1) 10229
.png)
No hay comentarios:
Publicar un comentario